Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Pfizer (NY: PFE)
44.06 USD  +0.31 (+0.71%)
Official Closing Price  /  Updated: 6:09 PM EDT, Sep 21, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 35,192,200
Open 43.78
Bid (Size) 43.76 (3)
Ask (Size) 44.05 (1)
Prev. Close 43.75
Today's Range 43.61 - 44.20
52wk Range 33.20 - 44.20
Shares Outstanding 5,849,571,048
Dividend Yield 3.04%
Performance
YTD
+20.91%
+20.91%
1 Month
+4.41%
+4.41%
3 Month
+21.11%
+21.11%
6 Month
+25.74%
+25.74%
1 Year
+22.53%
+22.53%
Top News
More News
This Gene Therapy Is 'About To Go Global'; Is The Dip An Opportunity?
Spark Therapeutics' gene therapy is "about to go global," an analyst said Friday after Europe came closer to approving the drug, Luxturna. Read More
from Investor's Business Daily
IBD Stock Of The Day: Fido's Drugmaker Nears Third Breakout Of 2018
Zoetis is the IBD Stock Of The Day as shares of Fido's drugmaker approached a buy point Friday after rival Elanco Animal Health began its second day of trading. Read More
from Investor's Business Daily
More News
Read More
Why Analysts Remain Bullish On This Biotech Despite Europe Rejection
from Investor's Business Daily
CEO Discusses IPO As Animal-Health Stock Rockets On First Day
from Investor's Business Daily
Opioids Are King, But Can Lilly, Regeneron Steal The Throne?
from Investor's Business Daily
Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
from Business Wire News Releases
Elanco Animal Health, Eventbrite IPOs Price Above Expectations
from Investor's Business Daily
New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting
from Business Wire News Releases
Pfizer Invites Public to View and Listen to Webcast of October 30 Conference Call with Analysts
from Business Wire News Releases
Eventbrite, Elanco IPOs Ready To Trade With High Demand For Shares
from Investor's Business Daily
Takeda lung cancer drug gets European panel nod
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.